Abstract:The (18 kDa) Translocator Protein (TSPO), was initially identified in 1977 as peripheral binding site for the benzodiazepine diazepam and named "Peripheral-type benzodiazepine receptor (PBR)". It is an evolutionarily well-conserved protein particularly located at the outer/inner mitochondrial membrane contact sites, in closely association with the 32 kDa voltage-dependent anion channel (VDAC) and the 30 kDa adenine nucleotide translocase (ANT), thus forming the mitochondrial permeability transition pore (MPTP). TSPO is ubiquitary expressed in peripheral tissues (steroid producing tissues, liver, heart, kidney, lung, immune system) and in lower levels in the central nervous system, where it is mainly located in glial cells, and in neurons. TSPO is involved in a variety of biological processes such as cholesterol transport, steroidogenesis, calcium homeostasis, lipid metabolism, mitochondrial oxidation, cell growth and differentiation, apoptosis induction, and regulation of immune functions. In the last decade, many studies have reported that TSPO basal expression is altered in a number of human pathologies, such as cancer and neurodegenerative disorders (Huntington's and Alzheimer's diseases), as well as in various forms of brain injury and inflammation and anxiety. Consequently, TSPO has not only been suggested as a promising drug target for a number of therapeutic applications (anticonvulsant, anxiolytic, immunomodulating, etc.), but also as valid diagnostic marker for related-disease state and progression, prompting the development of specific labelled ligands as powerful tools for imaging techniques. A number of structurally different classes of ligands have been reported, showing high affinity and selectivity towards TSPO. Indeed, most of these ligands have been designed starting from selective CBR ligands which were structurally modified in order to shift their affinity towards TSPO. Extensive structure-activity relationship studies were performed allowing to hypothesize various TSPO pharmacophore models. The purpose of this paper is to highlight the structural requirements needed to obtain TSPO ligands with high affinity and selectivity.

A Practical Process for the Synthesis of Translocator Protein 18kda Imidazopyridine Ligand

A New Method for the Synthesis of 4-Methoxyl-2,3,5-trimethylpyridine

New Synthesis Process of 2,7-Dimethyl-2,4,6-octatriene-1,8-dial

Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714

Structural Requirements to Obtain Highly Potent and Selective 18 kDa Translocator Protein (TSPO) Ligands

Radiosynthesis and evaluation of acetamidobenzoxazolone based radioligand [C-11]N '-MPB for visualization of 18 kDa TSPO in brain

Fluor NMR study of amino acid derived ligand to study TSPO

Scalable Process of Spiro(cyclopropane)oxazepane Pyridine Carboxylic Acid Through Kulinkovich, Mitsunobu, and Pd-Catalyzed Intramolecular C–N Coupling

An Improved Scalable Process for the Synthesis of (S,s)-Dach-ph Trost Ligand

Synthesis and pharmacological evaluation of [18F]PBR316: a novel PET ligand targeting the translocator protein 18 kDa (TSPO) with low binding sensitivity to human single nucleotide polymorphism rs6971

Design, synthesis, characterization and evaluation of methionine-ABO based TSPO ligand

A Simple And Efficient Route For Preparing 2,3,5,6-Tetraaminopyridine Hydrochloride Salt

Synthesis-free PET Imaging of Brown Adipose Tissue and TSPO Via Combination of Disulfiram and 64Cucl2.

Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

Organomediated Cleavage of Benzoyl Group Enables an Efficient Synthesis of 1-(6-nitropyridin-2-yl)thiourea and Its Application for Developing 18F-Labeled PET Tracers.

Automation of Copper-Mediated 18F-Fluorination of Aryl Pinacol Boronates Using 4-Dimethylaminopyridinium Triflate

ω-Transaminase-catalyzed synthesis of ( R )-2-(1-aminoethyl)-4-fluorophenol, a chiral intermediate of novel anti-tumor drugs

An Improved HPLC Separation Method for TSPO Radioligand [11C]ER176 Clinical Production

Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine

Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[18F]SFPy)

Catalytic asymmetric hydrogenation of ethyl 2-(benzo[b]thiophen-5-yl)-2- oxoacetate with ru-sunphos in the formal synthesis of T-588